High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
Clinical trial NCT02768792 · COMPLETED
Trial details
- NCT number
- NCT02768792
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-22
- Primary completion
- 2019-11-27
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.